• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>DRS

DRS

  1. All
  2. 3rd Party
  3. Investing
  1. Novare Pharmaceuticals Announces the Issuance of a U.S. patent for its RHAMM-Binding Peptides

    Novare Pharmaceuticals Announces the Issuance of a U.S. patent for its RHAMM-Binding Peptides

  2. Two Leading Researchers in Alzheimer’s Disease Receive 2015 MetLife Foundation Awards for Medical Research

    Two Leading Researchers in Alzheimer’s Disease Receive 2015 MetLife Foundation Awards for Medical Research

  3. C2N and AbbVie Announce FDA Orphan Drug Designation of C2N-8E12 (ABBV-8E12) for the Treatment of Progressive Supranuclear Palsy

    C2N and AbbVie Announce FDA Orphan Drug Designation of C2N-8E12 (ABBV-8E12) for the Treatment of Progressive Supranuclear Palsy

  4. U.S. PTO Issues Notice of Allowance for Patent using TB4 for Improving Neurological Outcomes After Injury and Neurodegenerative Disease

    U.S. PTO Issues Notice of Allowance for Patent using TB4 for Improving Neurological Outcomes After Injury and Neurodegenerative Disease

  5. BuzzAngle Music Revolutionizes Sales and Streaming Measurement With Highly-Interactive Daily Charts Sorted by Genre, City, Dates, and More

    BuzzAngle Music Revolutionizes Sales and Streaming Measurement With Highly-Interactive Daily Charts Sorted by Genre, City, Dates, and More

  6. Provident Bancorp, Inc. Announces Stock Offering Results And Expected Closing Date

    Provident Bancorp, Inc. Announces Stock Offering Results And Expected Closing Date

  7. USMD Adds Two Physicians to Support Growing Healthcare Needs of Patients

    USMD Adds Two Physicians to Support Growing Healthcare Needs of Patients

  8. Roger Ibbotson, Benoit Mandelbrot, and George Cooper

    Our distinguished economics panel debates the value of current risk models.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.